thymidine 5'-triphosphate has been researched along with pemetrexed in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andis, SL; Bewley, JR; Chen, VJ; Iversen, PW; Mendelsohn, LG; Schultz, RM; Seitz, DE; Shih, C; Tonkinson, JL | 1 |
| Chang, GC; Chen, KC; Hsu, KH; Hsu, SL; Hung, HW; Sheu, GT; Wu, CH; Yang, TY | 1 |
2 other study(ies) available for thymidine 5'-triphosphate and pemetrexed
| Article | Year |
|---|---|
Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.
Topics: Acid Anhydride Hydrolases; Antimetabolites, Antineoplastic; Deoxyribonucleotides; Enzyme Inhibitors; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Humans; Methotrexate; Nucleoside-Diphosphate Kinase; Nucleoside-Triphosphatase; Pemetrexed; Quinazolines; Ribonucleotides; Tetrahydrofolates; Thiophenes; Thymidylate Synthase; Thymine Nucleotides; Tumor Cells, Cultured | 1999 |
Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Cycle Proteins; Cell Line, Tumor; DNA Damage; DNA-Binding Proteins; Enzyme Activation; Glutamates; Guanine; Humans; Lung Neoplasms; Pemetrexed; Protein Serine-Threonine Kinases; S Phase Cell Cycle Checkpoints; Signal Transduction; Thymine Nucleotides; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2013 |